The results showed that circPTPN12-induced sunitinib resistance could be reversed by stattic, which implied that circPTPN12 facilitated sunitinib resistance in RCC cells via the STAT3 pathway (Fig. 4d). The gene discussed is STAT3; the disease is renal cell carcinoma.